Oncologix Tech Inc (OCLG) 0.0004 $OCLG
Oncologix Announces Third Quarter Results
Marketwired - Tue Jul 21, 8:35AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in Advanced Medical Products, Healthcare Services and Durable Medical product sales and distribution, announced its financial results for the three and nine months ending May 31, 2015 and May 31, 2014.
Oncologix Provides Acquisition Update
Marketwired - Thu May 14, 10:34AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product sales and distribution today updates its shareholders.
Oncologix Tech, Inc. Announces 2nd Quarter Fiscal 2015 Financial Results Showing Solid Revenue Growth and Continued Financial Improvements
Marketwired - Tue Apr 14, 8:38AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product sales and distribution, announced its financial results for the three and six months ending February 28, 2015 ("fiscal 2015"
and February 28, 2014 ("fiscal 2014" .
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 51.69 (unch), MDT: 84.26 (-0.33), MZOR: 17.65 (-0.63)
OCLG Provides Update on Its Proposed Acquisition of a Leading Medical Products Company
Marketwired - Mon Mar 16, 7:45AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating units in medical devices, medical products and healthcare services, announces update on proposed acquisition.
Oncologix Sees Immediate Results With Acquisition Of EsteemCare, Inc.
Marketwired - Wed Feb 11, 8:52AM CST
Oncologix Tech, Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product distribution, announces increased referrals and revenue growth with its recently acquired subsidiary, EsteemCare, Inc.
OCLG Continues Pursuit of Shareholder Value
Marketwired - Mon Jan 26, 8:26AM CST
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating units in medical devices, technologies and products, and healthcare services, announces continued note reduction strategy by retiring yet another convertible note.
OCLG Continues Convertible Debt Reduction Strategy; Strengthens Company's Shareholder Values
ACCESSWIRE - Tue Dec 30, 11:15AM CST
LAFAYETTE, LA / ACCESSWIRE / December 30, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating units in medical device, healthcare services, medical products and technologies, paid off another convertible note installment continuing its convertible debt reduction strategy in lieu of issuance of common stock shares.
Oncologix Tech, Inc. Announces 4th Quarter and 2014 Fiscal Year End Financial Results Showing Solid Revenue Growth and Continued Financial Improvements
ACCESSWIRE - Thu Dec 11, 8:15AM CST
LAFAYETTE, LA / ACCESSWIRE / December 11, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product distribution announced financial results for its fiscal 2014 and fourth quarter, ending August 31, 2014.
OCLG Continues Debt Reduction Strategy; Strengthens Company's Stock Position and Shareholder Value
ACCESSWIRE - Thu Dec 04, 8:18AM CST
Lafayette, LA / ACCESSSWIRE / December 4, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating units in medical device, healthcare services, medical products and technologies, announces the continuation of its convertible debt reduction strategy by repaying initial installment in lieu of issuance of common stock shares.
Oncologix Announces Third Quarter Results
Marketwired - Tue Jul 21, 8:35AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in Advanced Medical Products, Healthcare Services and Durable Medical product sales and distribution, announced its financial results for the three and nine months ending May 31, 2015 and May 31, 2014.
Oncologix Provides Acquisition Update
Marketwired - Thu May 14, 10:34AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product sales and distribution today updates its shareholders.
Oncologix Tech, Inc. Announces 2nd Quarter Fiscal 2015 Financial Results Showing Solid Revenue Growth and Continued Financial Improvements
Marketwired - Tue Apr 14, 8:38AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product sales and distribution, announced its financial results for the three and six months ending February 28, 2015 ("fiscal 2015"
and February 28, 2014 ("fiscal 2014" . Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 51.69 (unch), MDT: 84.26 (-0.33), MZOR: 17.65 (-0.63)
OCLG Provides Update on Its Proposed Acquisition of a Leading Medical Products Company
Marketwired - Mon Mar 16, 7:45AM CDT
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating units in medical devices, medical products and healthcare services, announces update on proposed acquisition.
Oncologix Sees Immediate Results With Acquisition Of EsteemCare, Inc.
Marketwired - Wed Feb 11, 8:52AM CST
Oncologix Tech, Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product distribution, announces increased referrals and revenue growth with its recently acquired subsidiary, EsteemCare, Inc.
OCLG Continues Pursuit of Shareholder Value
Marketwired - Mon Jan 26, 8:26AM CST
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating units in medical devices, technologies and products, and healthcare services, announces continued note reduction strategy by retiring yet another convertible note.
OCLG Continues Convertible Debt Reduction Strategy; Strengthens Company's Shareholder Values
ACCESSWIRE - Tue Dec 30, 11:15AM CST
LAFAYETTE, LA / ACCESSWIRE / December 30, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating units in medical device, healthcare services, medical products and technologies, paid off another convertible note installment continuing its convertible debt reduction strategy in lieu of issuance of common stock shares.
Oncologix Tech, Inc. Announces 4th Quarter and 2014 Fiscal Year End Financial Results Showing Solid Revenue Growth and Continued Financial Improvements
ACCESSWIRE - Thu Dec 11, 8:15AM CST
LAFAYETTE, LA / ACCESSWIRE / December 11, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating divisions in medical devices, healthcare services and durable medical product distribution announced financial results for its fiscal 2014 and fourth quarter, ending August 31, 2014.
OCLG Continues Debt Reduction Strategy; Strengthens Company's Stock Position and Shareholder Value
ACCESSWIRE - Thu Dec 04, 8:18AM CST
Lafayette, LA / ACCESSSWIRE / December 4, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating units in medical device, healthcare services, medical products and technologies, announces the continuation of its convertible debt reduction strategy by repaying initial installment in lieu of issuance of common stock shares.
